{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:19:05Z","timestamp":1781421545610,"version":"3.54.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T00:00:00Z","timestamp":1193356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/sj.eye.6703016","type":"journal-article","created":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T08:25:32Z","timestamp":1193387132000},"page":"1540-1541","source":"Crossref","is-referenced-by-count":11,"title":["Uveitis associated with concurrent administration of rifabutin and lopinavir\/ritonavir (Kaletra)"],"prefix":"10.1038","volume":"21","author":[{"given":"H-C","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P-L","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-H","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,26]]},"reference":[{"key":"BF6703016_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2165\/00003495-200666090-00012","volume":"66","author":"V Oldfield","year":"2006","unstructured":"Oldfield V, Plosker GL . Lopinavir\/ritonavir: a review of its use in the management of HIV infection. Drugs 2006; 66: 1275\u20131299.","journal-title":"Drugs"},{"key":"BF6703016_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/bjo.84.3.233","volume":"84","author":"ET Cunningham Jr","year":"2000","unstructured":"Cunningham Jr ET . Uveitis in HIV positive patients. Br J Ophthalmol 2000; 84: 233\u2013235.","journal-title":"Br J Ophthalmol"},{"key":"BF6703016_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archopht.1994.01090210043015","volume":"112","author":"BR Saran","year":"1994","unstructured":"Saran BR, Maquire AM, Nichols C, Frank I, Hertle RW, Brucker AJ et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994; 112: 1159\u20131165.","journal-title":"Arch Ophthalmol"},{"key":"BF6703016_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2165\/00003088-199528020-00003","volume":"28","author":"MH Skinner","year":"1995","unstructured":"Skinner MH, Blaschke TF . Clinical pharmacokinetics of rifabutin. Clin Pharmacokinet 1995; 28: 115\u2013125.","journal-title":"Clin Pharmacokinet"},{"key":"BF6703016_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00003088-200039030-00003","volume":"39","author":"JI Kuper","year":"2000","unstructured":"Kuper JI, D'Aprile M . Drug\u2013drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease. Clin Pharmacokinet 2000; 39: 203\u2013214.","journal-title":"Clin Pharmacokinet"},{"key":"BF6703016_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0009-9236(98)90036-4","volume":"63","author":"A Cato III","year":"1998","unstructured":"Cato III A, Cavanaugh J, Shi H, Hsu A, Leonard J, Granneman R . The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin. Clin Pharmacol Ther 1998; 63: 414\u2013421.","journal-title":"Clin Pharmacol Ther"},{"key":"BF6703016_CR7","unstructured":"Sun E, Heath-Chiozzi M, Cameron DW, Hsu A, Granneman RG, Maurath CJ . Concurrent ritonavir and rifabutin increases risk of rifabutin-associated adverse events. In Volume 1 of Program and abstracts of the 11th International Conference on AIDS, Vancouver, B.C., 7\u201312 July, 1996: 18 (abstract)."},{"key":"BF6703016_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","volume":"63","author":"RS Cvetkovic","year":"2003","unstructured":"Cvetkovic RS, Goa KL . Lopinavir\/ritonavir: a review of its use in the management of HIV infection. Drugs 2003; 63: 769\u2013802.","journal-title":"Drugs"},{"key":"BF6703016_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1345\/aph.1A363","volume":"36","author":"AH Corbett","year":"2002","unstructured":"Corbett AH, Lim ML, Kashuba AD . Kaletra (lopinavir\/ritonavir). Ann Pharmacother 2002; 36: 1193\u20131203.","journal-title":"Ann Pharmacother"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6703016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6703016","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6703016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:31:21Z","timestamp":1684413081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6703016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,26]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["BF6703016"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6703016","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,26]]}}}